Abstract
In aging males low serum testosterone is associated with cardiovascular disease. Testosterone replacement (TRT) can improve symptoms of cardiovascular disease, and in animal models of early atherosclerosis, such as the cholesterol-fed testicular feminised mouse (Tfm), TRT is also atheroprotective (Nettleship et al. 2007). The mechanisms underlying this are unclear, but since atherosclerosis is a chronic inflammatory disease testosterone may have an anti-inflammatory role.
| Original language | English |
|---|---|
| Pages | 12-12 |
| Number of pages | 1 |
| Publication status | Published - 2010 |
| Event | ASCEPT 44th Annual Scientific Meeting 2010 : Found in Translation: Integrated Approaches to Drug Development - Melbourne , Australia Duration: 28 Nov 2010 → 1 Dec 2010 http://ascept.eproceedings.com.au/ |
Conference
| Conference | ASCEPT 44th Annual Scientific Meeting 2010 |
|---|---|
| Abbreviated title | ASCEPT |
| Country/Territory | Australia |
| City | Melbourne |
| Period | 28/11/10 → 1/12/10 |
| Internet address |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Investigating the atheroprotective effect of testosterone: Role in modulation of inflammatory markers in the development of early atherogenesis in the testicular feminised mouse model'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver